Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review

Authors :: Patel, Girijesh
Perry, Josiah
Abdul-Rahim, Osama
Frankel, Arthur
Cameron, Daniel
Taylor, William
Rocconi, Rodney
Abushahin, Laith
Nelson, Cindy
Singh, Ajay
Khushman, Moh'D
Source :: Journal of Cancer Research and Therapeutics. Oct-Dec, 2020, Vol. 16 Issue 4, 950
Publication Year :: 2020
Abstract: Byline: Girijesh. Patel, Josiah. Perry, Osama. Abdul-Rahim, Arthur. Frankel, Daniel. Cameron, William. Taylor, Rodney. Rocconi, Laith. Abushahin, Cindy. Nelson, Ajay. Singh, Moh'd. Khushman Despite recent advances in treatment with multidrug [...]

Subjects :: Precision medicine
Vice presidents (Organizations)
Adenocarcinoma -- Care and treatment -- Genetic aspects
Osimertinib
Chemotherapy
Tyrosine -- Genetic aspects
Epidermal growth factors -- Genetic aspects
Erlotinib
Cancer metastasis -- Care and treatment -- Genetic aspects
Health

Tools